StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Did some calculation

<< Previous

Bullboard Posts

Next >>

Post by MarketMoneyon Jan 13, 2022 1:19pm

223 Views

Post# 34313503

RE:RE:RE:Did some calculation

@NewToinvesting7

Thanks for your input it's appreciated.

As for the advertising, I like the Tesla model of marketting. Tesla doesn't spend money on advertising instead they create a nice High Tech product which is superior the the tech in the current market and sell it to customer then let the customer do the work for them :-)

Thanks again and I like to believe 10 millions$/year of Aristotle testing is a good start for a nice futur growth of the company.

Have a great day

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)